Belgian investment firm Sofina Ventures divested a 1.28% stake in Mamaearth parent Honasa Consumer through a bulk deal worth ₹177 crore on June 25. In a separate institutional move, HDFC Mutual Fund increased its holding in hospital chain Global Health by acquiring shares from a co-founder.
What Happened
Belgian investment firm Sofina Ventures SA offloaded 41.78 lakh shares of Honasa Consumer, the parent company of the Mamaearth brand, on June 25, 2026. The transaction was executed through an open market operation, representing a 1.28% equity stake in the company. The sale was valued at approximately ₹177 crore, with shares changing hands at an average price of ₹424.07 per share. Following this sale, Sofina Ventures, which held a 3.29% stake as of March 2026, has reduced its exposure to the D2C (direct-to-consumer) company.
Why Institutional Exits Matter
For retail investors, the exit of a large private equity or venture capital investor like Sofina Ventures is a common event in the lifecycle of a listed company. When early-stage investors sell a portion of their holdings, it creates a supply of shares in the open market. While such deals are often part of a standard portfolio rebalancing or fund lifecycle strategy—rather than a reflection of the company's long-term business prospects—they can sometimes influence short-term price movement due to the sudden increase in liquidity.
Honasa Consumer: Financial Context
The company has recently reported its performance for the fourth quarter of the 2026 fiscal year, showing positive growth trends. Honasa Consumer posted a revenue of ₹657 crore for the quarter ended March 31, 2026, marking a 23% increase compared to the same period in the previous year. Profit after tax rose to ₹69.4 crore, up from ₹25 crore in the year-ago period. The company has been focusing on margin improvement and expanding its offline distribution network, with brands like The Derma Co. showing strong performance.
HDFC Mutual Fund's Move in Global Health
In a parallel development within the markets, HDFC Mutual Fund increased its stake in Global Health, the operator of the Medanta hospital chain. On June 24, the mutual fund acquired an additional 10 lakh shares, equivalent to a 0.37% stake, from co-founder Sunil Sachdeva. The transaction was valued at approximately ₹130 crore, with shares purchased at ₹1,300 each. This acquisition reflects continued interest from domestic institutional investors in India's growing hospital and healthcare sector, where demand for quality medical infrastructure remains high.
What Investors Should Monitor
Investors tracking Honasa Consumer may look beyond daily price movements and focus on the company's operational execution. Key monitorables include:
- Brand Performance: Sustainability of growth in flagship brands like Mamaearth and the scaling of newer brands like The Derma Co.
- Margin Trends: The company's ability to maintain profitability amidst competitive pressures in the FMCG sector.
- Offline Expansion: Progress in increasing the presence of its products across general trade outlets.
- Institutional Holdings: Future updates on shareholding patterns to see if other institutions absorb the supply created by departing private equity firms.